Stay updated on Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.

Latest updates to the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page
- Check6 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check12 days agoChange DetectedA banner announces that NIH websites are transitioning to use “Super Intelligence” instead of “Artificial Intelligence,” with links to updates and FAQs.SummaryDifference0.4%

- Check19 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check26 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry v3.7.0 was added to the record history and the previous revision v3.6.6 was removed. This updates the visible revision trail in the study history without changing substantive content.SummaryDifference0.1%

- Check69 days agoChange DetectedA new release note entry 'Revision: v3.6.6' was added to the history, and the previous 'Revision: v3.6.5' entry was removed, indicating an updated site version.SummaryDifference0.1%

Stay in the know with updates to Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.